A Trial to Evaluate the Effects of BCG in Adults With MCI and Mild-to-Moderate AD

Clinical trial NCT05004688 · COMPLETED

Trial details

NCT number: NCT05004688
Sponsor: Steven E Arnold, MD
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Mild Cognitive Impairment Mild Dementia Moderate Dementia Alzheimer Disease

Start date: 2022-03-25
Primary completion: 2024-01-15
Enrollment: 15

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.